Insights into the progression of genetic Alzheimer's disease from tau PET

Lancet Neurol. 2024 May;23(5):453-454. doi: 10.1016/S1474-4422(24)00124-8.
No abstract available

MeSH terms

  • Alzheimer Disease*
  • Amyloid beta-Peptides
  • Biomarkers
  • Cognitive Dysfunction*
  • Disease Progression
  • Humans
  • Positron-Emission Tomography
  • tau Proteins

Substances

  • tau Proteins
  • Amyloid beta-Peptides
  • Biomarkers